Growth and Development Until 18 Months of Children Exposed to Tocolytics Indomethacin or Nylidrin

Abstract Indomethacin, a prostaglandin synthesis inhibitor, is a more efficient tocolytic than the beta-sympathomimetic nylidrin, but causes more frequent unwanted effects in the neonatal period. In order to elucidate the effects on neurodevelopment, infants randomly exposed in utero to either compo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropediatrics 1996-08, Vol.27 (4), p.174-177
Hauptverfasser:	Salokorpi, T., Eronen, M., von Wendt, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Child Development - drug effects Drug toxicity and drugs side effects treatment Female Follow-Up Studies Growth - drug effects Humans Indomethacin - adverse effects Infant, Newborn Infant, Premature - growth & development Infant, Premature - physiology Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Nylidrin - adverse effects Original Articles Pharmacology. Drug treatments Pregnancy Prenatal Exposure Delayed Effects Sex Distribution Tocolytic Agents - adverse effects Treatment Outcome Triplets Twins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!